Matches in SemOpenAlex for { <https://semopenalex.org/work/W4366991371> ?p ?o ?g. }
Showing items 1 to 66 of
66
with 100 items per page.
- W4366991371 endingPage "20" @default.
- W4366991371 startingPage "16" @default.
- W4366991371 abstract "Background: Diabetic retinopathy (DR) is a major cause of blindness in working-age individuals in the developed countries. Studies have found that diabetic macular edema (DME) is a major cause of visual impairment in patients with diabetes mellitus (DM). Vascular endothelial growth factor (VEGF) plays an important role in the pathogenesis of DME. Material and Methods: Eighty-two patients (153 eyes) with DME were divided into two treatment groups. Group 1 (37 patients, 68 eyes) was treated with injections of the anti-VEGF agent brolucizumab according to the one plus pro re nata (PRN) regimen (once plus as needed) only, whereas group 2 (45 patients, 85 eyes) received a combination of “one plus PRN” brolucizumab therapy with subthreshold micropulse laser exposure (SMPLE). Before and after treatment, a comprehensive ophthalmological examination was performed, including the best-corrected visual acuity (BCVA) and the height of retinal edema in the central fovea as assessed by optical coherence tomography. The parameters were assessed at 1, 3, 6 and 12 months after treatment. Results: The percentage of patients with no need for additional anti-VEGF injections was substantially higher in the combined therapy group than in the monotherapy group (68.5% versus 12%, respectively, p <0.001). Conclusion: The combination treatment (intravitreal brolucizumab combined with SMPLE) for DME was effective in 68.5% of cases within 12 months. In this way, a steady resorption of DME is accomplished through antivasoproliferative and prolonged effects of brolucizumab and the SMPLE session." @default.
- W4366991371 created "2023-04-27" @default.
- W4366991371 creator A5028505374 @default.
- W4366991371 creator A5051710837 @default.
- W4366991371 date "2023-04-25" @default.
- W4366991371 modified "2023-09-29" @default.
- W4366991371 title "Comparing the effectiveness of brolucizumab therapy alone versus that combined with subthreshold micropulse laser exposure in the treatment of diabetic macular edema" @default.
- W4366991371 doi "https://doi.org/10.31288/oftalmolzh202321620" @default.
- W4366991371 hasPublicationYear "2023" @default.
- W4366991371 type Work @default.
- W4366991371 citedByCount "0" @default.
- W4366991371 crossrefType "journal-article" @default.
- W4366991371 hasAuthorship W4366991371A5028505374 @default.
- W4366991371 hasAuthorship W4366991371A5051710837 @default.
- W4366991371 hasBestOaLocation W43669913711 @default.
- W4366991371 hasConcept C118487528 @default.
- W4366991371 hasConcept C134018914 @default.
- W4366991371 hasConcept C141071460 @default.
- W4366991371 hasConcept C2776694085 @default.
- W4366991371 hasConcept C2777802072 @default.
- W4366991371 hasConcept C2778257484 @default.
- W4366991371 hasConcept C2778903070 @default.
- W4366991371 hasConcept C2779829184 @default.
- W4366991371 hasConcept C2780347916 @default.
- W4366991371 hasConcept C2780699112 @default.
- W4366991371 hasConcept C2780827179 @default.
- W4366991371 hasConcept C2780886150 @default.
- W4366991371 hasConcept C2781100027 @default.
- W4366991371 hasConcept C2985127711 @default.
- W4366991371 hasConcept C555293320 @default.
- W4366991371 hasConcept C71924100 @default.
- W4366991371 hasConceptScore W4366991371C118487528 @default.
- W4366991371 hasConceptScore W4366991371C134018914 @default.
- W4366991371 hasConceptScore W4366991371C141071460 @default.
- W4366991371 hasConceptScore W4366991371C2776694085 @default.
- W4366991371 hasConceptScore W4366991371C2777802072 @default.
- W4366991371 hasConceptScore W4366991371C2778257484 @default.
- W4366991371 hasConceptScore W4366991371C2778903070 @default.
- W4366991371 hasConceptScore W4366991371C2779829184 @default.
- W4366991371 hasConceptScore W4366991371C2780347916 @default.
- W4366991371 hasConceptScore W4366991371C2780699112 @default.
- W4366991371 hasConceptScore W4366991371C2780827179 @default.
- W4366991371 hasConceptScore W4366991371C2780886150 @default.
- W4366991371 hasConceptScore W4366991371C2781100027 @default.
- W4366991371 hasConceptScore W4366991371C2985127711 @default.
- W4366991371 hasConceptScore W4366991371C555293320 @default.
- W4366991371 hasConceptScore W4366991371C71924100 @default.
- W4366991371 hasIssue "2" @default.
- W4366991371 hasLocation W43669913711 @default.
- W4366991371 hasOpenAccess W4366991371 @default.
- W4366991371 hasPrimaryLocation W43669913711 @default.
- W4366991371 hasRelatedWork W2062091766 @default.
- W4366991371 hasRelatedWork W2087604601 @default.
- W4366991371 hasRelatedWork W2341140815 @default.
- W4366991371 hasRelatedWork W2465192560 @default.
- W4366991371 hasRelatedWork W2766144940 @default.
- W4366991371 hasRelatedWork W2790038519 @default.
- W4366991371 hasRelatedWork W2809088230 @default.
- W4366991371 hasRelatedWork W2922727180 @default.
- W4366991371 hasRelatedWork W3034231792 @default.
- W4366991371 hasRelatedWork W3063310417 @default.
- W4366991371 isParatext "false" @default.
- W4366991371 isRetracted "false" @default.
- W4366991371 workType "article" @default.